Antibiotics from gliding bacteria

Phytochemistry Reviews

Volumn 12, Issue 3, 2013, Pages 507-516

  Schmitz, Alexander ^a   Felder, Stephan ^a   Höver, Thomas ^a   Kehraus, Stefan ^a   Neu, Edith ^a   Lohr, Friederike ^a   König, Gabriele M ^a   Schäberle, Till F ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Biosynthetic gene cluster; Corallococcus coralloides; Corallopyronin; Marine myxobacteria; Myxopyronin; Polyketide

Indexed keywords

ANTIBIOTIC AGENT; CORALLOPYRONIN A; DAPTOMYCIN; FIDAXOMICIN; FRIULIMICIN; HALIANGICIN; NAI 107; NATURAL PRODUCT; NONRIBOSOMAL PEPTIDE SYNTHETASE; NVB 302; POLYKETIDE SYNTHASE; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ARTICLE; BACTERIAL STRAIN; CORALLOCOCCUS CORALLOIDES; DRUG STRUCTURE; ENHYGROMYXA SALINA; GENE CLUSTER; HALIANGIUM LUTEUM; HETEROLOGOUS EXPRESSION; MARINE BACTERIUM; MYXOCOCCALES; NONHUMAN; PHOTOTROPHIC, GLIDING, SHEATHED, BUDDING OR APPENDAGED BACTERIA; PRIORITY JOURNAL;

ACTINOBACTERIA (CLASS); CORALLOCOCCUS CORALLOIDES; MYXOCOCCALES;

EID: 84885326236     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-012-9224-x     Document Type: Article

References (40)

1. Belogurov GA, Vassylyeva MN, Sevostyanova A, Appleman JR, Xiang AX, Lira R, Webber SE, Klyuyev S, Nudler E, Artsimovitch I, Vassylyev DG (2009) Transcription inactivation through local refolding of the RNA polymerase structure. Nature 457:332-335
2. Bode HB, Müller R (2006) Analysis of myxobacterial secondary metabolism goes molecular. J Ind Microbiol Biotechnol 33:577-588
3. Butler MS, Cooper MA. (2011) Antibiotics in the clinical pipeline in 2011. J Antibiot (Tokyo) 64413-64425
4. Clardy J, Fischbach MA, Walsh CT (2006) New antibiotics from bacterial natural products. Nat Biotechnol 24:1541-1550
5. Coates A, Hu Y, Bax R, Page C (2002) The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov. 1:895-910
6. Davies J (2011) How to discover new antibiotics: harvesting the parvome. Curr Opin Chem Biol 15:5-10
7. Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D (2010) Sources of novel antibiotics. Appl Microbiol Biotechnol 88:1261-1267
8. Erol Ö, Schäberle TF, Schmitz A, Kehraus S, Piel J, Gurgui C, Rachid S, Müller R, König GM (2010) Biosynthesis of the myxobacterial antibiotic corallopyronin A. ChemBioChem 11:1253-1265
9. Fabbretti A, Gualerzi CO, Brandi L (2011) How to cope with the quest for new antibiotics. FEBS Lett 585:1673-1681
10. Fischbach MA (2009) Antibiotics from microbes: converging to kill. Curr Opin Microbiol 12:520-527
11. Fudou R, Iizuka T, Yamanaka S (2001a) Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 1. Fermentation and biological characteristics. J Antibiot (Tokyo) 54:149-152
12. Fudou R, Iizuka T, Sato S, Ando T, Shimba N, Yamanaka S (2001b) Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 2. Isolation and structural elucidation. J Antibiot (Tokyo) 54:153-156
13. Fudou R, Jojima Y, Iizuka T, Yamanaka S (2002) Haliangium ochraceum gen. nov., sp.nov. and Haliangium tepidum sp. nov.: Novel moderately halophilic myxobacteria isolated from coastal saline environments. J Gen Appl Microbiol 48:109-115
14. Gross H (2009) Genomic mining - a concept for the discovery of new bioactive natural products. Curr Opin Drug Discov Devel 12:207-219
15. Hamad B (2010) The antibiotics market. Nat Rev Drug Discov. 9:675-676
16. Hughes CC, Fenical W (2010) Antibacterials from the sea. Chem Eur J 16:12512-12525
17. Iizuka T, Jojima Y, Fudou R, Hiraishi A, Ahn JW, Yamanaka S (2003a) Plesiocystis pacifica gen. nov., sp. nov., a marine myxobacterium that contains dihydrogenated menaquinone, isolated from the Pacific coasts of Japan. Int J Syst Evol Microbiol 53:189-195
18. Iizuka T, Jojima Y, Fudou R, Tokura M, Hiraishi A, Yamanaka S (2003b) Enhygromyxa salina gen. nov., sp. nov., a slightly halophilic myxobacterium isolated from the coastal areas of Japan. Syst Appl Microbiol 26:189-196
19. Irschik H, Jansen R, Höfle G, Gerth K, Reichenbach H (1985) On antibiotics from gliding bacteria. The corallopyronins, new inhibitors of bacterial RNA-synthesis from myxobacteria. J Antibiot (Tokyo) 38:145-152
20. Irschik H, Schummer D, Höfle G, Reichenbach H, Steinmetz H, Jansen R (2007) Etnangien, a macrolide-polyene antibiotic from Sorangium cellulosum that inhibits nucleic acid polymerase. J Nat Prod 70:1060-1063
21. Jansen R, Irschnik H, Reichenbach H, Höfle G (1985) Corallopyronin A, corallopyronin B, and corallopyronin C - 3 novel antibiotics from Corallococcus coralloides. Liebigs Ann Chem 4:822-826
22. Kusebauch B, Busch B, Scherlach K, Roth M, Hertweck C (2010) Functionally distinct modules operate two consecutive α, β→β, γ double-bond shifts in the rhizoxin polyketide assembly line. Angew Chem Int Ed Engl 49:1460-1464
23. Li YZ, Hu W, Zhang YQ, Qiu ZJ, Zhang Y, Wu BH (2002) A simple method to isolate salt-tolerant myxobacteria from marine samples. J Microbiol Methods 50:205-209
24. Liu X, Ashforth E, Ren B, Song F, Dai H, Liu M, Wang J, Xie Q, Zhang L (2010) Bioprospecting microbial natural product libraries from the marine environment for drug discovery. J Antibiot (Tokyo) 63:415-422
25. Menche D, Arikan F, Perlova O, Horstmann N, Ahlbrecht W, Wenzel SC, Jansen R, Irschik H, Müller R (2008) Stereochemical determination and complex biosynthetic assembly of etnangien, a highly potent RNA polymerase inhibitor from the myxobacterium Sorangium cellulosum. J Am Chem Soc 130:14234-14243
26. Moldenhauer J, Götz DC, Albert CR, Bischof SK, Schneider K, Süssmuth RD, Engeser M, Gross H, Bringmann G, Piel J (2010) The final steps of bacillaene biosynthesis in Bacillus amyloliquefaciens FZB42: direct evidence for beta, gamma dehydration by a trans-acyltransferase polyketide synthase. Angew Chem Int Ed Engl 49:1465-1467
27. Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R, Irschik H, Arnold E, Ebright RH (2008) The RNA polymerase "switch region" is target for inhibitors. Cell 135:295-307
28. Mullane KM, Gorbach S (2011) Fidaxomicin: first-in-class macrocyclic antibiotic. Expert Rev Anti Infect Ther 9:767-777
29. Nett M, König GM (2007) The chemistry of gliding bacteria. Nat Prod Rep 24:1245-1261
30. O'Neill A, Oliva B, Storey C, Hoyle A, Fishwick C, Chopra I (2000) RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 44:3163-3166
31. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29-40
32. Piel J (2010) Biosynthesis of polyketides by trans-AT polyketide synthases. Nat Prod Rep 27:996-1047
33. Projan SJ (2003) Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 6:427-430
34. Reichenbach H (1993) Biology of myxobacteria: ecology and taxonomy. In: Dworkin M, Kaiser D (eds) Myxobacteria II. American Society for Microbiology, Washington, DC, pp 13-62
35. Reichenbach H (2001) Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol 27:149-156
36. Schäberle TF, Goralski E, Neu E, Erol Ö, Hölzl G, Dörmann P, Bierbaum G, König GM (2010) Marine myxobacteria as a source of antibiotics - Comparison of the physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina. Marine Drugs 8:2466-2479
37. Schiefer A, Schmitz A, Schäberle TF, Specht S, Lämmer C, Johnston KL, Vassylyev DG, König GM, Hoerauf A, Pfarr K (2012) Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo. J Infect Dis (in press)
38. Schneiker S, Perlova O, Kaiser O, Gerth K, Alici A, Altmeyer MO, Bartels D, Bekel T, Beyer S, Bode E et al (2007) Complete genome sequence of the myxobacterium Sorangium cellulosum. Nat Biotechnol 25:1281-1289
39. Singh SB, Young K (2010) New antibiotic structures from fermentations. Expert Opin Ther Pat 20:1359-1371
40. Wenzel SC, Müller R (2009) The biosynthetic potential of myxobacteria and their impact in drug discovery. Curr Opin Drug Discov Dev 12:220-230